by | Feb 20, 2024
Michel Robidoux President and General Manager, Sandoz Canada Dr. Jean-Pierre Raynauld MD, FRCPC, Rheumatologist Biosimilar Jubbonti® approved for all indications of Prolia* reference medicine.Sandoz continues to expand access for patients in Canada, offering denosumab...
by | Feb 20, 2024
FREMONT, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced key improvements and new features...
by | Feb 20, 2024
CEO Alexander Kinzler to Transition CEO Leadership to Barnwell of Canada President and COO Craig Hopkins Transition Aligned with Company’s New Focused Business Strategy HONOLULU, Feb. 20, 2024 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN)...
by | Feb 20, 2024
Please see below information about transactions made under the first tranche of the 2024 share buy-back programme for Equinor ASA (OSE:EQNR, NYSE:EQNR, CEUX:EQNRO, TQEX:EQNRO). Date on which the first tranche of the 2024 programme was announced: 7 February 2024. The...
by | Feb 20, 2024
Fleet utilization for January 2024 was 56.8 percent. Safe Notos and Safe Zephyrus had utilization of 100 percent in January. Safe Concordia was also fully utilized in the month with exception of a 5% discount on day rate due to a crane issue. Safe Concordia returned...
Recent Comments